Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Curr Opin Chem Biol. 2015 Jan 10;25:98–102. doi: 10.1016/j.cbpa.2014.12.017

Molecular recognition in protein modification with rhodium metallopeptides

Zachary T Ball 1
PMCID: PMC4380655  NIHMSID: NIHMS650676  PMID: 25588960

Abstract

Chemical manipulation of natural, unengineered proteins is a daunting challenge which tests the limits of reaction design. By combining transition-metal or other catalysts with molecular recognition ideas, it is possible to achieve site-selective protein reactivity without the need for engineered recognition sequences or reactive sites. Some recent examples in this area have used ruthenium photocatalysis, pyridine organocatalysis, and rhodium(II) metallocarbene catalysis, indicating that the fundamental ideas provide opportunities for using diverse reactivity on complex protein substrates and in complex cell-like environments.

Introduction

Chemically altered proteins are becoming increasingly important for chemical biology, biophysical measurements, protein-based therapeutics, and biomaterials studies. While our ability to perform chemical manipulations on protein substrates is crucial, proteins, and biopolymers in general, represent some of the most challenging “substrates” for chemical reactions. Selective chemistries must deal with the twin challenges of broad tolerance of demanding aqueous, functional-group-rich environments and selectivity in a sea of similarly reactive functional groups.

Nature, of course, performs selective post-translational modification as a matter of course. But natural proteins remain complicated and alien species for chemists.[13] Natural proteins themselves are often so intractable that engineered approaches to target structures have often been the only way forward. Unnatural amino acids can now be incorporated in many contexts, providing bio-orthogonal handles for subsequent manipulation. Natural “tagging” sequences can be engineered into a protein sequence to achieve similar goals.[13] Alternatively, residue-selective methods can and do furnish conjugates of natural proteins by covalently modifying a single residue type (lysine, tyrosine, tryptophan, etc.). But in general, amino acids are repetitive and selective chemistry must rely on local environment, secondary structure, or tertiary molecular recognition. Apart from a few cases where unique cysteine or N-terminal modification[4] is possible, residue-selective methods lead to product mixtures and don’t allow reactions in lysate, inside living cells, or in other complex environments. Selective catalysis on natural proteins, in any general way, remains an unsolved problem.

One approach to tackle the problem of natural proteins is combining a transition-metal catalyst with ligands that confer sequence- or site-selectivity on a catalytic reaction. In this conception, molecular recognition controls site-selectivity and increases reaction rate or productive reaction rate. Transition-metal catalysis has been a key player in the tremendous advances in small-molecule methodology development in recent decades. And is seemed clear to us that the non-traditional reactivity, non-biological mechanisms, and potentially low concentrations (loading) of transition-metal catalysts could offer significant advantages and opportunities. At the same time, proximity-driven reactivity is a hallmark of enzymatic catalysis—a part of even early lock-and-key models—and forms the basis for many designed protein tags and conjugation reactions. By combining these two concepts, new opportunities were envisioned. Among potential benefits, the molecular recognition motif (protein ligand) could be kept at catalytic concentrations—thus minimally perturbing the system—and could be separated from the tagging reagent—simplifying synthesis.

The prospect of de novo design of enzyme-like reactivity is an alluring one, and a variety of approaches using molecular recognition for catalysis have been pursued. The concepts of molecular recognition in catalysis show up in diverse fields,[5] including catalysis with dendrimers[68] and polymers, cyclodextrins,[911] and peptides[1214]. The most well studied and successful examples using biopolymer substrates have been proteolytic and other degradative reactions. Both Ni(II) and Cu(II) complexes induce DNA strand cleavage by oxidative mechanisms. Conjugates with DNA-binding proteins or small molecules allow the creation of DNA- or RNA-targeting probes with sequence-specificity.[1517] These ideas have also been used for the selective destruction of proteins.[18,19] Kostid [9] has used cyclodextrin-mediated molecular recognition of phenylalanine side chains to achieve proteolysis at Pro-Ser sequences (Figure 1). The result is an intriguing concept, but the selectivity and utility remains little explored. Pro-Ser motifs represent a middle ground between residue-selective and structure-selective approaches. It remains to be seen how useful dipeptide recognition might be in the context of larger biomolecules.

Figure 1.

Figure 1

(A) Cyclodextrin–palladium conjugates promote proteolysis at Pro–Ser sequences [9]. (B) Copper-catalyzed peptide cleavage at serine. (C) Sequence of ubiquitin, with serine residues highlighted.

More recently, copper-catalyzed selective oxidative peptide cleavage has been demonstrated with a serine oxidation catalyst. (Figure 1B,C).[20] A presumed initial oxidation of the side-chain hydroxyl is followed by oxidative C–C cleavage to provide an oxalate derivative, which hydrolyzes under the reaction conditions. The work is a significant demonstration of the utility of catalyst design to control reactivity in complex systems. The authors achieve selective oxidation of the serine hydroxyl with O2, even though oxidation of electron-rich aromatic and sulfur-containing side chains is well studied with other catalysts. The authors due note some side products from reaction at those oxidation-prone side chains, but nonetheless were able to demonstrate oxidative cleavage of the three serine sites in ubiquitin, a chemical analogue of enzymatic protein degradation that delivers completely new selectivity. The authors observed and identified the cleavage fragments (1–19, 21–56, and 58–64) by protein gel and by mass spec. At this point, the chemistry is residue-selective, targeting all serine side chains, and new approaches would be needed to provide specificity for single sites within larger proteins.

Molecular recognition has been used to wonderful effect in facilitating photoredox chemistry at protein surfaces (Figure 2). Oxidative coupling of tyrosine side chains near the binding site occurred with electron-rich dimethylaniline reagents. Bringing photocatalysis to bear on protein chemistry problems brings with it the potential for spatial and temporal control of reactivity in new and valuable ways. Thus far, model proteins BSA and carbonic anhydrase (CA) have been successfully modified, and future work should provide an understanding of the generality and possibilities of this approach. In a metal-free implementation of these ideas, the Hamachi group, in a series of exciting papers, has demonstrated that “catalysts” as simple as pyridine can efficiently modify lysine near a binding site, via acylation of acylpyridinium intermediates. intermediate.[21] The work grew out of previous efforts to develop selective modification with traditional electrophiles intermediates, such as tosylates, when it was discovered that catalytic methods delivered improved efficacy. This catalytic approach allow for simple “traceless” modification and the improved efficiency allowed labeling the surface of living cells, an unmet challenge with previous approaches.

Figure 2.

Figure 2

A catalytic approach for SET-based tyrosine labeling.[22]

To address the problem, we investigated rhodium(II) metallopeptide catalysts.[23] The dirhodium(II) tetracarboxylate center was employed for selective side-chain modification, based on a report of tryptophan modification with stabilized diazo reagents.[24] The peptide ligand could be viewed as a molecular recognition motif, delivering the reactive rhodium(II) complex to specific side chains on the surface of a target protein. Importantly, the dirhodium(II) tetracarboxylate core is stable to hydrolysis, ligand exchange, and decomposition under physiologically relevant conditions, yet contains weakly-held axial ligands (opposite the Rh–Rh bond) that readily dissociate, allowing catalysis in water. We developed general methods to synthesize diverse and complex (we have made complexes up to 30 amino acids) metallopeptides, including, where necessary, a protecting-group strategy for carboxylate deprotection after metalation to enable selective metalation of sequences with multiple carboxylates.[25]

We initially began to explore the topic by studying modification of coiled-coil peptides, which we viewed as a simplistic model for protein-protein interactions (Figure 3). Based on a well-studied model [26], we used rhodium(II) metallopeptides with coil structure to catalyze modification of specific residues flanking the coiled-coil interface. The known tryptophan reactivity[24] could be replicated in this system, and molecular recognition had a profound effect on reactivity: a >1000x increase in reaction rate for template catalysis was seen relative to unstructured peptide substrates.[27]

Figure 3.

Figure 3

Proximity-driven modification of a designed E3/K3 coiled-coil.

Tryptophan is uniquely reactive with simple Rh2(OAc)4 catalysis. In contrast, proximity-driven catalysis with a metallopeptide allowed selective reactions at many other residues, completely unreactive in reactions with Rh2(OAc)4. The phenylalanine benzene ring; terminal carboxylates and carboxamides from asparagine, aspartate, glutamine, and glutamate; and the arginine guanidine group were part of the surprising breadth of side-chain functionality that could be effectively modified.[23] Recently, rhodium(II) catalysis has also been used for oligonucleotide modification [28], where interesting structure selectivity was observed.

The proximity-driven catalysis could be extended to natural protein substrates, using a proline-rich metallopeptide that binds to SH3 domains (Figure 4a) [29]. Attaching a rhodium complex to S2, L3, or R5 positions on the proline-rich peptide ligand allows efficient modification of W42.

Figure 4.

Figure 4

(A) The Fyn SH3 domain is efficiently modified by diazo reagents specifically at W42 with the catalysts S2ERh, L3ERh, and R5ERh. The 13DRh serves as an inactive negative control. (B) Modification of proteins in lysate. Proteins containing two different coil sequences (E3g2W or E3e2W) are effectively and individually conjugated with the biotin—diazo reagent 1b, depending on catalyst choice. Biotin-specific blot (at right) demonstrates the potential for designed orthogonal reactivity.

In addition to the breadth of reactivity, rhodium metallopeptides are active in cell lysate (Figure 4a) [29,30]. Lysate from E. coli producing desired substrate proteins could be directly treated with a biotinylated diazo reagent 1b and an appropriate catalyst, resulting in orthogonal modification of specific proteins, depending on the structure of the catalyst chosen[30]. A thorough study of rhodium placement at different points on the coil structure was used to optimize reactivity and orthogonality of the designed coils, E3g2W and E3e2W [30].

Future directions

Studies into molecular recognition for designed, non-biological transition-metal catalysis have opened up new doors as well. Histidine and methionine residues retard catalysis through coordination with the rhodium center [31,32 ]. This has opened new opportunities to use rhodium coordination in developing targeted, metal-based protein inhibitors [25,31,32 ]. Though conceptually straightforward, this approach is surprisingly little-investigated. A cobalt-based approach for targeted inhibition of transcription factors is a noteworthy recent addition to this research area [33,34].

From a fundamental perspective, the catalytic approach outlined here begins to provide approaches for selectivity on polyfunctional substrates and in polyfunctional environments. Small molecule synthesis is traditionally controlled by inherent chemical reactivity. Despite what is now decades of effort to overcome this limitation and develop selective reactions that rival enzymatic transformations, successful examples are rare—such as recent examples with complex natural products [35,36]—and are just beginning to touch the surface of what is possible.

Catalytic, site-specific protein modification, perhaps most importantly, provides a tool to synthesize new biomaterials and bioconjugates quickly and easily. The ideas conveyed here have been used to modify and label specific targets in living systems, to modify structures common to a broad domain class (SH3), or to develop proteolytic activity with specificity rivaling natural enzymes. The future possibilities in this area are immense. Diverse fields and factors are combining to make these studies especially important going forward: Proteins and protein conjugates are increasingly viewed as promising drug candidates; a focus on green and smart materials creates new opportunities for novel biomaterials; and improved methods that allow routine biopolymer analysis (especially mass spectrometry) greatly simplify the task of characterizing reaction “products” that might be 100 kDa or more. Taken together, catalytic chemistry, site-specificity, and efficient, highly selective reactions provide unique and increasing opportunities in diverse fields.

Highlights.

  • New ideas are needed for chemical modification of natural proteins.

  • Enzyme-like selectivity is possible by combining catalysts with molecular recognition ideas.

  • Current examples include complex environments including living systems.

  • Rhodium(II) catalysis provides a broad amino-acid substrate scope for implementation of molecular recognition ideas.

Acknowledgments

I gratefully acknowledge financial support from the Robert A. Welch Foundation Research Grant C-1680 from the National Science Foundation under grant number CHE-1055569.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References and recommended reading

  • 1.Stephanopoulos N, Francis MB. Choosing an effective protein bioconjugation strategy. Nat Chem Biol. 2011;7:876–884. doi: 10.1038/nchembio.720. [DOI] [PubMed] [Google Scholar]
  • 2.Hinner MJ, Johnsson K. How to obtain labeled proteins and what to do with them. Curr Opin Biotechnol. 2010;21:766–776. doi: 10.1016/j.copbio.2010.09.011. [DOI] [PubMed] [Google Scholar]
  • 3.Romanini DW, Cornish VW. Protein labelling: Playing tag with proteins. Nat Chem. 2012;4:248–250. doi: 10.1038/nchem.1325. [DOI] [PubMed] [Google Scholar]
  • 4.Witus LS, Netirojjanakul C, Palla KS, Muehl EM, Weng CH, Iavarone AT, Francis MB. Site-specific protein transamination using N-methylpyridinium-4-carboxaldehyde. J Am Chem Soc. 2013;135:17223–17229. doi: 10.1021/ja408868a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Raynal M, Ballester P, Vidal-Ferran A, van Leeuwen PWNM. Supramolecular catalysis. Part 2: artificial enzyme mimics. Chem Soc Rev. 2014;43:1734–1787. doi: 10.1039/c3cs60037h. [DOI] [PubMed] [Google Scholar]
  • 6.Astruc D, Chardac F. Dendritic catalysts and dendrimers in catalysis. Chem Rev. 2001;101:2991–3023. doi: 10.1021/cr010323t. [DOI] [PubMed] [Google Scholar]
  • 7.Delort E, Darbre T, Reymond JL. A strong positive dendritic effect in a peptide dendrimer-catalyzed ester hydrolysis reaction. J Am Chem Soc. 2004;126:15642–15643. doi: 10.1021/ja044652p. [DOI] [PubMed] [Google Scholar]
  • 8.Helms B, Fréchet JMJ. The dendrimer effect in homogeneous catalysis. Adv Synth Catal. 2006;348:1125–1148. [Google Scholar]
  • 9.Milovid NM, Badjid JD, Kostid NM. Conjugate of Palladium(II) Complex and β-Cyclodextrin Acts as a Biomimetic Peptidase. J Am Chem Soc. 2004;126:696–697. doi: 10.1021/ja038404p. [DOI] [PubMed] [Google Scholar]
  • 10.Yang J, Gabriele B, Belvedere S, Huang Y, Breslow R. Catalytic oxidations of steroid substrates by artificial cytochrome P-450 enzymes. J Org Chem. 2002;67:5057–5067. doi: 10.1021/jo020174u. [DOI] [PubMed] [Google Scholar]
  • 11.Fang Z, Breslow R. Metal coordination-directed hydroxylation of steroids with a novel artificial P-450 catalyst. Org Lett. 2006;8:251–254. doi: 10.1021/ol052589i. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Severin K, Lee DH, Martinez JA, Vieth M, Ghadiri MR. Dynamic Error Correction in Autocatalytic Peptide Networks. Angew Chem Int Ed. 1998;37:126–128. [Google Scholar]
  • 13.Lee DH, Granja JR, Martinez JA, Severin K, Ghadiri MR. A self-replicating peptide. Nature. 1996;382:525–528. doi: 10.1038/382525a0. [DOI] [PubMed] [Google Scholar]
  • 14.Kennan AJ, Haridas V, Severin K, Lee DH, Ghadiri MR. A de Novo Designed Peptide Ligase: A Mechanistic Investigation. J Am Chem Soc. 2001;123:1797–1803. doi: 10.1021/ja991266c. [DOI] [PubMed] [Google Scholar]
  • 15.Joyner JC, Keuper KD, Cowan JA. Kinetics and mechanisms of oxidative cleavage of HIV RRE RNA by Rev-coupled transition metal-chelates. Chem Sci. 2013;4:1707–1718. doi: 10.1039/C3SC22135K. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Long EC. Ni(II)•Xaa-Xaa-His metallopeptide—DNA/RNA interactions. Acc Chem Res. 1999;32:827–836. [Google Scholar]
  • 17.Jin Y, Lewis MA, Gokhale NH, Long EC, Cowan JA. Influence of stereochemistry and redox potentials on the single- and double-strand DNA cleavage efficiency of Cu(II)-and Ni(II)·Lys-Gly-his- derived ATCUN metallopeptides. J Am Chem Soc. 2007;129:8353–8361. doi: 10.1021/ja0705083. [DOI] [PubMed] [Google Scholar]
  • 18.Gokhale NH, Bradford S, Cowan JA. Catalytic inactivation of human carbonic anhydrase I by a metallopeptide-sulfonamide conjugate is mediated by oxidation of active site residues. J Am Chem Soc. 2008;130:2388–2389. doi: 10.1021/ja0778038. [DOI] [PubMed] [Google Scholar]
  • 19.Gokhale NH, Cowan JA. Inactivation of human angiotensin converting enzyme by copper peptide complexes containing ATCUN motifs. Chem Commun. 2005:5916–5918. doi: 10.1039/b511081e. [DOI] [PubMed] [Google Scholar]
  • 20.Seki Y, Tanabe K, Sasaki D, Sohma Y, Oisaki K, Kanai M. Serine-Selective Aerobic Cleavage of Peptides and a Protein Using a Water-Soluble Copper–Organoradical Conjugate. Angew Chem Int Ed. 2014;53:6501–6505. doi: 10.1002/anie.201402618. [DOI] [PubMed] [Google Scholar]
  • **21.Wang H, Koshi Y, Minato D, Nonaka H, Kiyonaka S, Mori Y, Tsukiji S, Hamachi I. Chemical Cell-Surface Receptor Engineering Using Affinity-Guided, Multivalent Organocatalysts. J Am Chem Soc. 2011;133:12220–12228. doi: 10.1021/ja204422r. Acylpyridinium intermediates enable specific protein modification. This paper demonstrates molecular recognition of natural proteins on living cells. [DOI] [PubMed] [Google Scholar]
  • 22.Sato S, Nakamura H. Ligand-directed selective protein modification based on local single-electron-transfer catalysis. Angew Chem Int Ed. 2013;52:8681–8684. doi: 10.1002/anie.201303831. [DOI] [PubMed] [Google Scholar]
  • 23.Popp BV, Ball ZT. Proximity-driven metallopeptide catalysis: Remarkable side-chain scope enables modification of the Fos bZip domain. Chem Sci. 2011;2:690–695. [Google Scholar]
  • 24.Antos JM, Francis MB. Selective tryptophan modification with rhodium carbenoids in aqueous solution. J Am Chem Soc. 2004;126:10256–10257. doi: 10.1021/ja047272c. [DOI] [PubMed] [Google Scholar]
  • 25.Zaykov AN, Ball ZT. A general synthesis of dirhodium metallopeptides as MDM2 ligands. Chem Commun. 2011;47:10927–10929. doi: 10.1039/c1cc13169a. [DOI] [PubMed] [Google Scholar]
  • 26.Litowski JR, Hodges RS. Designing heterodimeric two-stranded α-helical coiled-coils - Effects of hydrophobicity and α-helical propensity on protein folding, stability, and specificity. J Biol Chem. 2002;277:37272–37279. doi: 10.1074/jbc.M204257200. [DOI] [PubMed] [Google Scholar]
  • 27.Popp BV, Ball ZT. Structure-selective modification of aromatic side chains with dirhodium metallopeptide catalysts. J Am Chem Soc. 2010;132:6660–6662. doi: 10.1021/ja101456c. [DOI] [PubMed] [Google Scholar]
  • 28.Tishinov K, Schmidt K, Häussinger D, Gillingham DG. Structure-Selective Catalytic Alkylation of DNA and RNA. Angew Chem Int Ed. 2012;51:12000–12004. doi: 10.1002/anie.201205201. [DOI] [PubMed] [Google Scholar]
  • **29.Chen Z, Vohidov F, Coughlin JM, Stagg LJ, Arold ST, Ladbury JE, Ball ZT. Catalytic Protein Modification with Dirhodium Metallopeptides: Specificity in Designed and Natural Systems. J Am Chem Soc. 2012;134:10138–10145. doi: 10.1021/ja302284p. Designed rhodium metallopeptide catalysts with orthogonal substrate reactivity allow modification of different proteins in lysate, depending on catalyst choice. [DOI] [PubMed] [Google Scholar]
  • 30.Chen Z, Popp BV, Bovet CL, Ball ZT. Site-Specific Protein Modification with a Dirhodium Metallopeptide Catalyst. ACS Chem Biol. 2011;6:920–925. doi: 10.1021/cb2001523. [DOI] [PubMed] [Google Scholar]
  • 31.Kundu R, Cushing PR, Popp BV, Zhao Y, Madden DR, Ball ZT. Hybrid Organic–Inorganic Inhibitors of a PDZ Interaction that Regulates the Endocytic Fate of CFTR. Angew Chem Int Ed. 2012;51:7217–7220. doi: 10.1002/anie.201202291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Popp BV, Chen Z, Ball ZT. Sequence-specific inhibition of a designed metallopeptide catalyst. Chem Commun. 2012;48:7492–7494. doi: 10.1039/c2cc33808d. [DOI] [PubMed] [Google Scholar]
  • *33.Harney AS, Lee J, Manus LM, Wang P, Ballweg DM, LaBonne C, Meade TJ. Targeted inhibition of Snail family zinc finger transcription factors by oligonucleotide-Co(III) Schiff base conjugate. Proc Natl Acad Sci U S A. 2009;106:13667–13672. doi: 10.1073/pnas.0906423106. Cobalt-histidine interactions play a key role in anchoring designed ligands to a transcriptiona-factor target, greatly improving potency. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Hurtado RR, Harney AS, Heffern MC, Holbrook RJ, Holmgren RA, Meade TJ. Specific Inhibition of the Transcription Factor Ci by a Cobalt(III) Schiff Base–DNA Conjugate. Molecular Pharmaceutics. 2012;9:325–333. doi: 10.1021/mp2005577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Pathak TP, Miller SJ. Chemical tailoring of teicoplanin with site-selective reactions. J Am Chem Soc. 2013;135:8415–8422. doi: 10.1021/ja4038998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • *36.Lichtor PA, Miller SJ. Combinatorial evolution of site- and enantioselective catalysts for polyene epoxidation. Nat Chem. 2012;4:990–995. doi: 10.1038/nchem.1469. Catalyst libraries to enable site-selective epoxidation on polyene substrates with little to no inherent selectivity. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES